CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,262 enrolled
Drug / intervention
Colonoscopy with EndoCuff™ +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02345889
NCT02345889N/ACompleted
CompareCT.gov

A 4-arm Randomized Controlled Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy

Indiana University·interventional·Posted Jan 26, 2015·Updated Mar 12, 2019

In Brief

A clinical study evaluating Colonoscopy with EndoCuff™, FUSE® Colonoscopy, and 2 other interventions for Colorectal Neoplasms. Completed, enrolled 1,262 participants across 1 site.

Detailed Summary

Adenoma detection rate (ADR) is a validated marker for reducing the risk of interval colorectal cancer after a screening colonoscopy. Recent studies suggest that novel devices attached to the colonoscope tip may improve the ADR of doctors performing a screening procedure

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Neoplasms
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 26, 2015
Enrollment StartFeb 1, 2015
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.4 years ago

Interventions

Colonoscopy with EndoCuff™device

colonoscopy performed with an EndoCuff™ device at the tip of a standard colonoscope

FUSE® Colonoscopydevice

colonoscopy performed with the FUSE® (full spectrum endoscopy) system

Colonoscopy with EndoRings™device

colonoscopy performed with an EndoRings™ device at the tip of a standard colonoscope

Standard Colonoscopydevice

Current standard of care colonoscopy